| Logo | Name | Σ | ||
|---|---|---|---|---|
 | WILCO [Automatic translation follows] Liberator of ambitions that helps women and men realize their innovative transformation projects. Challenger. Disrupter. Transform Create economic value. Positively impact society. This is what drives the WILCO teams. startups, honor loan, innovation, fundraising, Open Innovation, FrenchTech, Digital, Healthcare, Industry, Health, Fundraising, Acceleration, ETI, Large Groups, Corporate, and Intrapreneurship | 628 | 149 | 544 |
 | Laboratoires Expanscience [Automatic translation follows] Well-being is in our hands We haven't given our all for over 70 years without a good reason. At Expanscience, we are a mission-driven company, and our purpose is to help everyone shape their well-being, from childhood to seniorhood. This is what drives our 1,000 employees forward, research and innovate, every day! Independent at heart, we are a French company, 100% family-owned, with products (Mustela, Piasclédine 300, etc.) available in over 100 countries. For us, it's clear: the well-being of women and men is inseparable from the health of the planet, and is in the hands of … Sectors: | 217 | 119 | 103 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 3486 | 2601 | 833 |
 | Leem [Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its … Sectors: | 721 | 384 | 261 |
 | GSK We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines Sectors: | 1080 | 705 | 402 |
 | STATION F The biggest startup campus in the world. STATION F is the world's biggest startup campus based in Paris, gathering a whole entrepreneurial ecosystem under one roof. Startups Sectors: | 3279 | 2829 | 390 |
 | BFM Business [Automatic translation follows] France's leading economic and financial news channel. BFM Business TV is France's leading economic and financial news channel. It stands out for its programming focused on the search for expertise. Programs focusing on economic news have established themselves as economic news events. "Good Morning Business" for example, offers guests, the latest innovations, editorials and information on underlying trends on its set. BFM Business TV is also available live on our website as well as on a dedicated application. Tech, Stock Market, Economy, Real Estate, Business, Automobile, and High-Tech Sectors: | 7833 | 7044 | 872 |
 | ANSM Agence nationale de sécurité du médicament et des produits de santé [Automatic translation follows] For safe, effective, innovative and accessible health products The National Agency for the Safety of Medicines and Health Products is the public actor that allows, on behalf of the State, access to health products in France and ensures their safety throughout their life cycle. At the heart of the health system, we act in the service of patients and their safety. We promote access to innovative products via authorization procedures adapted to each stage of the life of the drug before and after it is placed on the market. Through our assessments, our expertise and our monitoring … | 149 | 100 | 32 |
Cosmetics